Search results
Merck Reports Progress On The Cancer Front As It Prepares For Keytruda Patent Expiration
Benzinga via Yahoo Finance· 1 hour agoAfter topping expectations with first quarter revenue and adjusted earnings last week, Merck & Co...
Cerevance receives milestone payment under Alzheimer's collaboration with Merck
Seeking Alpha· 4 hours agoPrivately held Cerevance receives milestone payment from Merck for Alzheimer's research...
Merck reports data from Phase III gastric cancer treatment trial
Clinical Trials Arena via Yahoo Finance· 12 hours agoLast month, MSD announced positive data from the Phase III STRIDE-10 trial of its investigational...
Moderna posts better-than-expected quarterly results as it looks to fall RSV vaccine launch
Market Watch· 10 hours agoModerna Inc. on Thursday reported a narrower-than-expected first-quarter loss as the COVID vaccine...
Is Moderna Stock A Buy On Its Eye-Popping First-Quarter Sales Beat?
Investor's Business Daily· 4 hours agoMeanwhile, Moderna is expanding its efforts in cancer treatment. The company is partnered with Merck...
Moderna COVID vaccine sales plummet 91 percent - The Boston Globe
The Boston Globe· 5 hours agoSales of Moderna’s COVID-19 vaccine plunged 91 percent from the previous year for the first quarter...
Merck reports promising V116 vaccine trial results By Investing.com
Investing.com· 3 days agoMerck & Co. (NYSE: MRK) has presented new data from its Phase 3 STRIDE-10 trial of V116, an...
Moderna plants new solid tumor trials for cancer vaccine, weeds PD-1 work after review
FierceBiotech· 5 hours agoModerna detailed plans for its individual neoantigen cancer vaccine in a first-quarter earnings...
Moderna (MRNA) Q1 Earnings Beat Estimates, Revenues Down Y/Y
Zacks via Yahoo Finance· 5 hours agoModerna is co-developing mRNA-4157 with Merck. Since the onset of 2024, the companies have initiated...
Moderna cancer vaccine offers long-term hope in melanoma
Proactive Investors· 6 days agoCovid vaccine maker Moderna Inc and partner Merck Sharp and Dohme (MSD) have initiated a phase III...